J&J subpoenaed for products sold to Omnicare
Executive Summary
J&J is responding to a subpoena for eight products sold to Omnicare, the company says in its 10-Q filing. The company reported receiving the subpoena from the U.S. Attorney's office in Massachusetts on Sept. 26. In July, J&J received a subpoena related to the sales and marketing of its congestive heart failure drug Natrecor (nesiritide). Omnicare broadened its long-term care pharmacy practice and specialty pharmaceutical distribution through the acquisition of NeighborCare and RxCrossroads in July (1"The Pink Sheet" July 11, 2005, p. 16)...